Molecular Underpinnings of Brain Metastases

Maria A Jacome1, Qiong Wu2, Jianan Chen2

  • 1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

Insights

Brain metastases, common CNS tumors, arise from various cancers. Understanding their complex mechanisms, including tumor microenvironment and blood-brain barrier penetration, is crucial for developing effective treatments.

Area of Science:

  • Neuro-oncology
  • Cancer Metastasis Research
  • Molecular Oncology

Background:

  • Brain metastases represent the most frequent central nervous system tumors.
  • Mechanisms underlying brain metastasis development remain largely unknown.
  • Common primary sources include lung, breast, and melanoma, with renal and colorectal cancers also implicated.

Purpose of the Study:

  • To review the current understanding of brain metastasis pathophysiology.
  • To explore genetic characteristics of primary tumors and molecular mechanisms of CNS spread.
  • To discuss challenges in targeted therapies and identify knowledge gaps.

Main Methods:

  • Literature review synthesizing current research on brain metastases.
  • Analysis of common and tumor-specific mechanisms of metastatic progression.
  • Examination of genetic and molecular factors influencing central nervous system colonization.

Main Results:

  • Common pathways include tumor microenvironment adaptation, cell priming, vascular survival, and blood-brain barrier penetration.
  • Tumor-specific genetic and molecular interactions complicate metastatic progression.
  • Significant challenges persist in developing targeted therapies for brain metastases.

Conclusions:

  • A comprehensive understanding of brain metastasis pathophysiology requires integrating tumor-specific genetics with common metastatic mechanisms.
  • Further research is needed to bridge knowledge gaps and improve therapeutic strategies for patients.
  • Targeted therapies for brain metastases face hurdles due to complex underlying biology.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K